Transformative Pharmaceutical Solutions, LLC (TPS) develops unique platforms designed to transform the Clinical Research Industry. Our integrated suite of people, process, and technology solutions are designed to transform the way Pharmaceutical companies, Biotechnology companies and Investigative Sites monitor clinical trials. Our platforms are designed to integrate with sponsor and site infrastructures, significantly increasing operational transparency, efficiency and overall trial quality.

Nucleus is a precise talent attraction and management solution that uses AI and machine learning to maximize match and improve retention in the Life Sciences and Biotech industries. Our smart platform provides the structure and resources required to quickly build the quality teams needed to enable breakthrough discoveries in advanced therapeutics, biopharma, diagnostics, research tools, and adjacent technologies.

TayganPoint executive retained by Grant Thornton, the sixth largest accounting firm in the US with annual revenue of $1.9B. Consultant and trusted advisor to the client executive teams and program/project managers.• Advised global medical device company on M&A lifecycle processes and development of integration playbook across all functional areas. • Assessed global manufacturing company on Order-to-Cash and Procure-to-Pay processes for redesign and alignment with supply chain improvement while developing business requirements for new ERP.• Directed a clinical trial software development company on redesigned IT processes, finance transformation, and S&OP performance improvement. Advised private-equity investors and executive management on strategy, improving business valuation and facilitating recapitalization. • Advisor to multiple growing global clinical trial supply companies on operations modeling for expanding IT and cloud-based ERP system. Directed business and functional requirements for GmP, GcP, and system validation (21CFR Part 11/Annex 11) as well as current and future-state process documentation.

Strategized, established or revamped, and directed finance, accounting, risk management, Operations, IT infrastructure and strategy, HR, Business Development, and strategic partnerships supporting aggressive growth of a professional services firm. Led due diligence and business valuation leading to company acquisition by Grant Thornton.• Co-proposed and led company’s repositioning to global life sciences focus, facilitating 250% revenue growth and subsequent acquisition. • Established New Business Development function, global partnerships, branding and go-to-market strategies, yielding three-fold growth in client acquisition. • Developed and collaborated on executing Five Keys to Growth plan, realizing significant revenue growth and business valuation increase.• Rebuilt the HR function, eliminating outsourcing, implementing best practices, and achieving employee turnover rate 5% to 10% below industry average.• Developed an enterprise-wide operational business process eliminating silos and standardizing and centralizing control, processes and communications nationally through corporate training.

Collaborated with new CEO and private-equity firm to turnaround and stabilize a multi-national, bilingual market research data collection company. Restructured or established operational and infrastructure capabilities, operating plans, budgets, financial controls and reporting, analytical methods, capital management strategy, IT operations, and strategic growth initiatives. • Rebuilt the HR function and leadership for 600+ workforce in multiple states and Mexico, reducing turnover from 200%+ to 25% for call centers.• Reduced fixed OpEx by 25% year over year.• Developed new business model and FP&A that resulted in successful loan deferment, significant investment in CapEx near-shore, reduced operating costs, new revenue streams, and business value increase. • Improved business-dependent IT infrastructure uptime from 85% to 99.9%, decreasing lost revenue to $0.• Referral from private-equity firm: “…brought on to help transform ERS’ entire accounting/financial and HR departments, but ended up being instrumental in the transformation of the entire company.”

Multi-faceted global organization with multiple business units within non-profit parent organization including MSCHE accredited educational institution. Appointed to Finance and Executive Committees directing international, graduate level educational institution and non-profit organization. Accountable for strategic planning, management and leadership of entire finance, accounting, human resources, legal, information technology, facilities maintenance as well as day-to-day operations management. Provided all revenue and expense related information – financial reporting, budgeting, and forecasting – to the board of directors.Developed financial reporting standards for MSCHE accreditation – seminary was granted accreditation status in 2009 requiring extensive financial reporting structure.Coordinated year-end audit with outside auditors and submission of all corporate tax filings while continuing to improve accounting and operational controls. Managed first-ever financial audit for non-profit organization and developed audit committee by-laws.

A member of Inc Magazine’s INC500 list of privately held firms and recognized by VARBusiness as one of the 50 Fastest Growing Solutions Providers in North America, Omicron is a leading technology implementation firm serving corporate and plant environments.Chief Financial Officer, 2004 to 2008Controller, 1999 to 2004Assistant Controller, 1996 to 1999Full decision-making responsibility for legal negotiations and contracts, audit committee activities, treasury functions, investments, insurance, and health benefits, in addition to fiscal responsibilities as Controller. Worked closely with the Wachovia Bank N.A. on line-of-credit management. Contributing member of Executive Management Planning Group. Clients include Microsoft, Bank of America, Merck, Bristol-Myers Squibb, Amgen, GlaxoSmithKline, General Electric, ConocoPhillips, and Biogen-Idec.Provided all revenue and expense related information – financial reporting, budgeting, and forecasting – to senior management through direct report of project management, productivity analysis, and operating controls. Recommended operational and financial improvements based on extensive financial analysis.Contributed to Omicron’s industry recognition in three categories - 1) the first dual Gold Certified partner for Microsoft, 2) the first Gold Partner for OSIsoft, and 3) Gold Partner Certification with Hewlett Packard. Coordinated year-end audit with outside auditors and submission of all corporate tax filings while continuing to improve accounting and operational controls. Reduced audit time from four months to two weeks, by implementing an internal monthly review process.Managed 401k investments, risk analysis, insurance requirements, ESOP, cash requirements and bank relations and covenants through detailed management of collection, billing process, and treasury; managed currency exchange risk with foreign customers by transacting in forward contracts.

Audited manufacturing, government, financial service, and not-for-profit companies for preparation of singular or multi-corporate financial statements. Prepared federal and multi-state individual, partnership, and corporate tax returns. Consulted with clients on development of efficient general ledger systems and financial reporting packages for internal reporting purposes.

Audited computer software and manufacturing companies. Assisted in preparation of SEC reports for initial public offering (IPO) of a computer programming company.